Correlation Between Microsoft and Ventana Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and Ventana Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Ventana Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Ventana Biotech, you can compare the effects of market volatilities on Microsoft and Ventana Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Ventana Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Ventana Biotech.

Diversification Opportunities for Microsoft and Ventana Biotech

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Microsoft and Ventana is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Ventana Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventana Biotech and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Ventana Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventana Biotech has no effect on the direction of Microsoft i.e., Microsoft and Ventana Biotech go up and down completely randomly.

Pair Corralation between Microsoft and Ventana Biotech

Given the investment horizon of 90 days Microsoft is expected to generate 0.13 times more return on investment than Ventana Biotech. However, Microsoft is 7.64 times less risky than Ventana Biotech. It trades about -0.06 of its potential returns per unit of risk. Ventana Biotech is currently generating about -0.21 per unit of risk. If you would invest  42,729  in Microsoft on August 26, 2024 and sell it today you would lose (1,029) from holding Microsoft or give up 2.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Microsoft  vs.  Ventana Biotech

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Ventana Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ventana Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Ventana Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Microsoft and Ventana Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and Ventana Biotech

The main advantage of trading using opposite Microsoft and Ventana Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Ventana Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will offset losses from the drop in Ventana Biotech's long position.
The idea behind Microsoft and Ventana Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm